Biosimilars Five-Year Savings Outlook For Employer Plans Looks Meager -- Analysis
This article was originally published in The Pink Sheet Daily
Executive Summary
Costs are likely to be reduced by only a few percentage points in the next few years, less than some have anticipated, AbbVie-commissioned study suggests.